No Data
No Data
No Data
No Data
No Data
PINKDX LAUNCHES WITH $40 MILLION SERIES A FINANCING TO DEVELOP DIAGNOSTICS ADDRESSING UNMET MEDICAL NEEDS FOR WOMEN
The company, led by diagnostics industry veteran Bonnie Anderson,also names Alison Cowan, M.D., M.S.C.R., as chief medical officer Catalio Capital Management and The Production Board co-led the finan
PR NewswireApr 25 21:00
Veracyte to Release First Quarter 2024 Financial Results on May 7, 2024
Veracyte, Inc. (NASDAQ:VCYT) announced today that it will release financial results for the first quarter of 2024 after the close of market on Tuesday, May 7, 2024. Company management will host a conference call and
BusinesswireApr 23 05:00
New Study Shows Veracyte's Decipher Prostate Test Is Prognostic for Prostate Cancer Progression Among Patients Undergoing Active Surveillance
Veracyte, Inc. (NASDAQ:VCYT), a leading cancer diagnostics company, today announced that a new study published in JCO Precision Oncology shows that, among patients undergoing Active Surveillance (AS) for prostate
BusinesswireApr 22 20:30
Investors Don't See Light At End Of Veracyte, Inc.'s (NASDAQ:VCYT) Tunnel
With a price-to-sales (or "P/S") ratio of 4x Veracyte, Inc. (NASDAQ:VCYT) may be sending very bullish signals at the moment, given that almost half of all the Biotechs companies in the United States h
Simply Wall StApr 17 19:33
Veracyte Announces That Nine Studies Reinforcing the Value of Decipher Prostate and Decipher Bladder Testing Will Be Presented at AUA 2024
Business WireApr 16 20:30
Veracyte Is Maintained at Buy by Goldman Sachs
Veracyte Is Maintained at Buy by Goldman Sachs
Dow JonesApr 15 22:44
No Data
No Data